SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-24-001759
Filing Date
2024-01-10
Accepted
2024-01-10 17:00:58
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 ny20016597x1_s3.htm S-3 802343
2 EXHIBIT 4.13 ny20016597x1_ex4-13.htm EX-4.13 455424
3 EXHIBIT 4.15 ny20016597x1_ex4-15.htm EX-4.15 140269
4 EXHIBIT 4.16 ny20016597x1_ex4-16.htm EX-4.16 118552
5 EXHIBIT 4.17 ny20016597x1_ex4-17.htm EX-4.17 104519
6 EXHIBIT 5.1 ny20016597x1_ex5-1.htm EX-5.1 50336
7 EXHIBIT 23.1 ny20016597x1_ex23-1.htm EX-23.1 2324
8 FILING FEES TABLE ny20016597x1_ex107.htm EX-FILING FEES 17411
9 logohonigman.jpg GRAPHIC 247412
10 logo_jonestrading.jpg GRAPHIC 24352
11 logo_ocuphire.jpg GRAPHIC 75522
12 logo_ocuphirex1.jpg GRAPHIC 60098
  Complete submission text file 0001140361-24-001759.txt   2252919
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276462 | Film No.: 24527179
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)